Hematology Frontier

As vibrant blossoms filled the streets of Shanghai and the Huangpu River shimmered beneath the morning sun, the 2025 Hematology Translational and Innovation Conference, held in parallel with the 10th Shanghai Lymphoid Disease Symposium, was convened from June 27 to 29. This prominent academic event brought together leading experts from China and abroad to share research achievements and foster the translation of basic science into clinical advances. With a focus on innovative therapies, professional education, and scientific communication, the conference provided a dynamic platform for collaboration and progress.

As summer bloomed in Shanghai and the tide of the Huangpu River caught the morning light, the 2025 Hematology Translational and Innovation Conference, held in parallel with the 10th Shanghai Lymphoid Disease Symposium, took place from June 27 to 29. This major academic event welcomed prominent experts from China and abroad to share cutting-edge achievements, promote the integration of basic science and clinical application in hematology, and foster broad exchanges around emerging therapies, professional training, and science communication.

From June 20 to 22, the 19th Annual Meeting of the Chinese Medical Doctor Association Hematology Branch and the 2025 China Hematology Conference (CAH 2025) was held in the historic city of Xi’an. As a major academic event in China’s hematology community, the conference maintained its core mission of “serving clinical practice,” with a strong focus on treatment standardization, practical application, and multicenter collaboration, fostering deep integration of academic exchange and clinical implementation. During the event, Oncology Frontier – Hematology Frontier interviewed Professor Jin Lu from Peking University People's Hospital, Executive Chair of CAH 2025, for an in-depth conversation on the highlights of this year’s conference and the development of multiple myeloma (MM) care in China.

In early summer, the historic city of Xi’an welcomed a gathering of leading experts at the 19th Annual Meeting of the Chinese Association of Hematologists and the 2025 China Annual Hematology Conference (CAH 2025), held from June 20 to 22. The event was co-hosted by the Chinese Medical Doctor Association and its Hematology Branch, in collaboration with the National Clinical Research Center for Hematologic Diseases – Peking University Institute of Hematology, and the First Affiliated Hospital of Xi’an Jiaotong University.

The 54th Annual Scientific Meeting of the International Society for Experimental Hematology (ISEH 2025) will be held in Kumamoto, Japan, from September 24 to 27, 2025. One of the major…

The 18th International Conference on Malignant Lymphoma (ICML), organized by the Institute of Oncology Research (IOR), was held from June 17 to 21, 2025, in Lugano, Switzerland. As one of…

The 18th International Conference on Malignant Lymphoma (ICML), organized by the Institute of Oncology Research (IOR), was held from June 17 to 21, 2025, in Lugano, Switzerland. As the most…

The 18th International Conference on Malignant Lymphoma (ICML), hosted by the Institute of Oncology Research (IOR), was held from June 17 to 21, 2025, in Lugano, Switzerland. As the world’s…

Editor’s Note: From June 6–8, 2025, the “2025 International Symposium on Clinical and Translational Hematology and the 10th Two Rivers Forum on Hematologic Malignancies” was held in Chongqing, China. The…

In this exclusive interview with Infectious Diseases Frontier, Professor Simone Cesaro, a leading expert in pediatric hematology and stem cell transplantation, shares his perspectives on the management of BK polyomavirus-associated hemorrhagic cystitis (HC) following hematopoietic cell transplantation (HCT). Drawing from the findings of a recent EBMT survey, he discusses the clinical implications of passive surveillance strategies, platelet transfusion thresholds, and the urgent need for consensus guidelines to support transplant centers across Europe. His insights underscore the importance of early intervention and standardization in addressing this often-overlooked complication.